Gastric cancer (GC) is 4th in incidence and mortality rates globally. Several genetic and
epigenetic factors, including microRNAs (miRNAs), affect its initiation and progression …

Gastric cancer (GC) is one of the most common malignant tumors of digestive systems
worldwide, with high recurrence and mortality. Chemotherapy is still the standard treatment …

Background Gastric cancer (GC) is one of the malignant tumors with the highest morbidity
and mortality in the world. Early diagnosis combined with surgical treatment can significantly …

Head and neck cancer (HNC), which includes epithelial malignancies of the upper
aerodigestive tract (oral cavity, oropharynx, pharynx, hypopharynx, larynx, and thyroid), are …

Multi-drug resistance (MDR) is the major hindrance towards the successful treatment of
malignant lung cancer. The aim of this study was to develop a novel nanoparticle co-loaded …

Purpose Colorectal cancer (CRC) is one of the most lethal and prevalent cancers throughout
the world. Despite the remarkable advance in the field, drug resistance still remains as an …

Purpose Due to the lack of specific and sensitive detection indicators, most patients with GC
are already in the advanced stage at the time of diagnosis. Therefore, it is urgent to search …

Background Dedifferentiated liposarcoma (DDLPS), a tumor that lacks effective treatment
strategies and is associated with poor outcomes, expresses amplified MDM2 in the …

Gastric cancer (GC) is the third leading cause of cancer-related mortality worldwide. The
poorly prognosis and survival of GC are due to diagnose in an advanced, non-curable stage …

Ribonuclease Dicer initiates gene-silencing process by cleaving exogenously long RNA
duplexes into small interfering RNA (siRNA) or endogenous precursor microRNAs (pre …